Sofdra

Sofdra is a topical anticholinergic gel for adults and children aged 9 and up suffering from underarm excessive sweating (primary axillary hyperhidrosis). Applied at bedtime, it helps reduce sweat production by blocking signals to sweat glands

Molecule Details :

  • Molecule Name :

    Sofpironium
  • Innovator :

    BOTANIX SB INC
  • Approval Date :

    18-Jun-24
  • NCE-1 Date :

    18-Jun-28
  • NCE Date :

    18-Jun-29
  • Dosage Form :

    Metered Gel Topical
  • Strength :

    EQ 12.45% BASE (EQ 72MG BASE-ACTUATION)
  • Therapeutic Category :

    Antiperspirant
  • Revenue ($M) :

    NA

Year-wise Projected Sales ($M) :

  • 2025 :

    NA
  • 2026 :

    NA
  • 2027 :

    NA
  • 2028 :

    NA
  • 2029 :

    NA
  • 2030 :

    NA
  • 2031 :

    NA
Looking for this molecule for your next clinical research? Access regulatory-compliant comparators with assured timelines—delivered reliably through our global network.

Why Choose Spring Bio Solution?

Supported 1000+ Clinical Trials globally

Provides services across regulatory, legal & clinical research

Unmatched intelligence on batches, expiry, spacing, and historical data from innovators

Integrated CRO Services as part of our offerings

Insights on global pricing for smarter clinical trial supply decisions 


Login NCE Grid

Register NCE Grid

Are you sure want to logout from NCE Grid?